PERSPECTA

News from every angle

← Back to headlines

NATCO Pharma launches generic blood cancer treatment medicine in U.S.

The product is available in 1mg, 2mg, 3mg, and 4mg strengths and is distributed primarily through specialty pharmacies and clinics, NATCO Pharma said

4 Mar, 12:32 — 4 Mar, 12:32
PostShare
Only 1 source covers this story